The outcomes were provided today by lead investigator Colin M.

The outcomes were provided today by lead investigator Colin M. Barker, M.D., at the Cardiovascular Analysis Foundation’s annual scientific symposium, Transcatheter Cardiovascular Therapeutics 2011 in SAN FRANCISCO BAY AREA. ‘These were high-risk patients who got no alternatives because these were not candidates for surgery,’ said Barker, associate professor of cardiology at the UTHealth Medical School and an attending physician at Memorial Hermann Heart & Vascular Institute . ‘We performed interventional stenting on these 10 patients with no complications or deaths.’ Related StoriesPurple Button cellular app helps HMC achieve overall goal of improving patient basic safety, qualityPeople with high fitness levels in midlife have lower annual health care costs after age 65Drinking one 16-ounce energy drink may increase risk of cardiovascular occasions in young adultsThe individuals, who had symptoms of stroke linked to their carotid artery disease, had been evaluated by James C.‘The identification of a novel and possibly common ALS disease gene from a straightforward yeast display, leveraged by the more technical model developed in fruit flies, underscores the incredible power of yeast and fly as model systems for attaining insight into individual disease pathogenesis,’ Bonini stated.. Cenpatico, MHS expand Catasys’ OnTrak program to Medicare Advantage users in Wisconsin Catasys, Inc. , provider of proprietary wellness management services to health insurers and employers, announced today that Cenpatico and Managed Health Solutions , a Centene health plan in Wisconsin, have expanded Catasys' OnTrak program to MHS' eligible Medicare Advantage people in Wisconsin.